Association of the TNF2 Allele with Eclampsia
- 1 May 2004
- journal article
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- Vol. 57 (4) , 204-209
- https://doi.org/10.1159/000076689
Abstract
The genetic background predisposing pregnant women to the disorder pre-eclampsia/eclampsia (PE/E) is still unknown. There is compelling evidence to suspect involvement of the immune system in the development of PE/E. The aim of this current study was to investigate whether there is an association between the tumor necrosis factor (TNF)-α –307 polymorphism and PE or eclampsia. In this study, 51 cases of eclampsia, 122 cases of PE and 100 normotensive control cases were genotyped for the TNF-α –307 polymorphism. We found a significant difference between the TNF2 allele frequencies of eclamptic and normotensive controls (χ2 = 6.3 and p = 0.025), but not of pre-eclamptic and normotensive controls (χ2 = 0.5 and p = 1.0). We conclude from this study that the TNF2 allele contributes to the occurrence of eclampsia in our population.Keywords
This publication has 17 references indexed in Scilit:
- Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor α and lymphotoxin α genes and plasma tumor necrosis factor α levelsAmerican Journal of Obstetrics and Gynecology, 2001
- A Genome Scan in Families from Australia and New Zealand Confirms the Presence of a Maternal Susceptibility Locus for Pre-Eclampsia, on Chromosome 2American Journal of Human Genetics, 2000
- Prothrombin G20210A Mutation: Is It Associated with Pre-Eclampsia?Gynecologic and Obstetric Investigation, 2000
- Polymorphism in the promoter region of tumor necrosis factor-alpha gene is associated with severe melioidosisHuman Immunology, 1999
- Plasma tumor necrosis factor-α soluble receptor p55 (sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean womenJournal of Reproductive Immunology, 1998
- Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis.The Journal of Experimental Medicine, 1995
- Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and TobagoThe Lancet, 1993
- Angiotensinogen: a candidate gene involved in preeclampsia?Nature Genetics, 1993
- Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/eclampsia and HLA DRβThe Lancet, 1990
- Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells.The Journal of Experimental Medicine, 1987